Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth E Powell

Showing results (61-70 of 113) with videos related to

Pageof 12
Sort By:
Digestive Diseases (Basel, Switzerland)|November 3, 2022
Serum CC-Chemokine Ligand 2 Is Associated with Visceral Adiposity but Not Fibrosis in Patients with Non-Alcoholic Fatty Liver DiseaseMichelle Ferrari-Cestari, Satomi Okano, Preya J Patel, et al.
Annals of Hepatology|July 19, 2023
Lower prevalence of elevated liver stiffness measurements in people with type 2 diabetes taking sodium-glucose co-transporter 2 inhibitors or glucagon-like peptide-1 receptor agonistsLucy Gracen, Withma Muthukumara, Melanie Aikebuse, et al.
BMC Gastroenterology|July 14, 2022
Poor disease knowledge is associated with higher healthcare service use and costs among patients with cirrhosis: an exploratory studyPatricia C Valery, Christina M Bernardes, Kelly L Hayward, et al.
Internal Medicine Journal|August 8, 2017
Optimising care of patients with chronic disease: patient-oriented education may improve disease knowledge and self-managementKelly L Hayward, Leigh U Horsfall, Brittany J Ruffin, et al.
The Lancet Regional Health. Western Pacific|July 31, 2025
A population-based study of cause-specific mortality in First Nations Australians with cirrhosis: impact of cardiometabolic comorbidities and liver disease risk factorsVikas Bhasker, Catherine Brown, Jessica R Fong, et al.
JCI Insight|October 5, 2016
CRIg-expressing peritoneal macrophages are associated with disease severity in patients with cirrhosis and ascitesKatharine M Irvine, Xuan Banh, Victoria L Gadd, et al.
Eclinicalmedicine|July 19, 2019
Increasing Hospitalization Rates for Cirrhosis: Overrepresentation of Disadvantaged AustraliansElizabeth E Powell, Richard Skoien, Tony Rahman, et al.
BMJ Open Gastroenterology|September 18, 2020
ICD-10-AM codes for cirrhosis and related complications: key performance considerations for population and healthcare studiesKelly L Hayward, Amy L Johnson, Benjamin J Mckillen, et al.
Journal of Magnetic Resonance Imaging : JMRI|September 30, 2008
Magnetic resonance imaging and spectroscopy for monitoring liver steatosisGary J Cowin, Julie R Jonsson, Judith D Bauer, et al.
Eclinicalmedicine|June 18, 2021
Hepatocellular carcinoma amongst Aboriginal and Torres Strait Islander peoples of AustraliaAlan J Wigg, Sumudu K Narayana, Gunter Hartel, et al.
Pageof 12

Showing results (61-70 of 113) with videos related to

Sort By:
Pageof 12
Digestive Diseases (Basel, Switzerland)|November 3, 2022
Serum CC-Chemokine Ligand 2 Is Associated with Visceral Adiposity but Not Fibrosis in Patients with Non-Alcoholic Fatty Liver DiseaseMichelle Ferrari-Cestari, Satomi Okano, Preya J Patel, et al.
Annals of Hepatology|July 19, 2023
Lower prevalence of elevated liver stiffness measurements in people with type 2 diabetes taking sodium-glucose co-transporter 2 inhibitors or glucagon-like peptide-1 receptor agonistsLucy Gracen, Withma Muthukumara, Melanie Aikebuse, et al.
BMC Gastroenterology|July 14, 2022
Poor disease knowledge is associated with higher healthcare service use and costs among patients with cirrhosis: an exploratory studyPatricia C Valery, Christina M Bernardes, Kelly L Hayward, et al.
Internal Medicine Journal|August 8, 2017
Optimising care of patients with chronic disease: patient-oriented education may improve disease knowledge and self-managementKelly L Hayward, Leigh U Horsfall, Brittany J Ruffin, et al.
The Lancet Regional Health. Western Pacific|July 31, 2025
A population-based study of cause-specific mortality in First Nations Australians with cirrhosis: impact of cardiometabolic comorbidities and liver disease risk factorsVikas Bhasker, Catherine Brown, Jessica R Fong, et al.
JCI Insight|October 5, 2016
CRIg-expressing peritoneal macrophages are associated with disease severity in patients with cirrhosis and ascitesKatharine M Irvine, Xuan Banh, Victoria L Gadd, et al.
Eclinicalmedicine|July 19, 2019
Increasing Hospitalization Rates for Cirrhosis: Overrepresentation of Disadvantaged AustraliansElizabeth E Powell, Richard Skoien, Tony Rahman, et al.
BMJ Open Gastroenterology|September 18, 2020
ICD-10-AM codes for cirrhosis and related complications: key performance considerations for population and healthcare studiesKelly L Hayward, Amy L Johnson, Benjamin J Mckillen, et al.
Journal of Magnetic Resonance Imaging : JMRI|September 30, 2008
Magnetic resonance imaging and spectroscopy for monitoring liver steatosisGary J Cowin, Julie R Jonsson, Judith D Bauer, et al.
Eclinicalmedicine|June 18, 2021
Hepatocellular carcinoma amongst Aboriginal and Torres Strait Islander peoples of AustraliaAlan J Wigg, Sumudu K Narayana, Gunter Hartel, et al.
Pageof 12